Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Increased risk of fentanyl adverse effects
Management
If coadministering, monitor therapeutic effects and adverse reactions (e.g. sedation, respiratory depression)
Info Source
